Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck …

2025年1月24日 · What is cetuximab? Cetuximab is used to treat cancers of the colon and rectum. It is also used to treat head and neck cancer. Cetuximab may also be used for purposes not …

Cetuximab is approved to be used alone or with other drugs to treat: Colorectal cancer that has spread to other parts of the body. It is used: In patients whose cancer has the EGFR protein …

2023年5月1日 · Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor with the following FDA-approved indications: colorectal cancer, metastatic, KRAS wild-type (without …

2025年3月1日 · Cetuximab injection is used together with radiation treatment for advanced squamous cell carcinoma of the head and neck (SCCHN), or with a platinum-based cancer …

Cetuximab is a type of targeted cancer drug. It is a treatment for advanced bowel cancer and neck cancers. Find out about how you have it, possible side effects and other important information.

ERBITUX results in approximately 22% higher blood levels of cetuximab as compared to the European version of ERBITUX. It is possible that U.S. patients receiving ERBITUX may …

2024年3月1日 · Erbitux (cetuximab) is used to treat cancers of the colon and rectum. Learn about side effects, interactions and indications.

Cetuximab is a medication that treats colorectal cancer. This type of cancer develops from polyps (growths) in your colon’s inner lining. Cetuximab can also treat head and neck cancer.

Cetuximab is an endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck.